Identification of a serum three-microRNA signature for cervical cancer diagnosis
Chin Med J (Engl)
.
2021 Jan 5;134(14):1756-1758.
doi: 10.1097/CM9.0000000000001327.
Authors
Min-Min Cao
1
,
Qing-Xie Liu
1
,
Xuan Zou
2
,
Xing-Chen Fan
1
,
Cheng Liu
3
,
Shi-Yu Zhang
1
,
Tong-Shan Wang
1
,
Chun-Yu Li
4
,
Cheng Zhang
5
,
Xiang-Nan Geng
6
,
Ping Liu
1
,
Wei Zhu
1
Affiliations
1
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
2
Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
3
Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
4
Department of Intensive Care Unit, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
5
Department of Science and Technology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
6
Department of Clinical Engineer, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
PMID:
33410629
PMCID:
PMC8318658
DOI:
10.1097/CM9.0000000000001327
No abstract available
Publication types
Letter
MeSH terms
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs* / genetics
Uterine Cervical Neoplasms* / diagnosis
Uterine Cervical Neoplasms* / genetics
Substances
MicroRNAs